DatasetName,BRD3_S(261) BRD3_S(268) BRD3_S(455) BRD3_S(555) BRD3_S(563) BRD3_S(682) BRD3_T(249) BRD3_T(250),BRD3_S(260) BRD3_S(263) BRD3_S(3) BRD3_S(558) BRD3_S(560) BRD3_S(680) BRD3_S(681) BRD3_T(257) BRD3_Y(561) BRD3_Y(632)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5106930572578393,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.5994075089183604
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.49405430635255254,0.6115518584957205
NJH2025_Sub12_HIIT_Mid,0.47452486466398375,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,0.5045070642011461,
JJ2018_Ratio H/M normalized pP2,,0.6098625082841969
NJH2025_Sub12_MICT_Pre,0.4811115850034188,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.4958663753245649,0.5910994031571108
HS2024_6_B_T3,0.4888940303374822,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.48807321007433446,0.6115389883574177
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5035278802306964,0.6242078479068582
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.512960454488558,
AST2020_anti-CD3.2,,0.6098097205307751
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.47162592416044546,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.6141533308399574
RB2022_5_PreEndurance,,0.6108634106305953
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.621843679940881
EP2017_Untreated R#4 normalized log2 ratio,0.5184250370401908,0.5969499450355122
WZ2023_Pu_010_30min,0.5001890291808532,0.641085242985368
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,0.6091627863435333
KBE2022_Log2_Ex_14_U,,0.6273151900306801
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,0.60949942398376
ZQ2022_C2,,
RB2022_5_PreSprint,,0.6125564974812051
PG2020_Intensity 8h_C,0.483585234743509,0.597057947893366
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,0.5135488633458114,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.490923776869604,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.5993005089788224
UK2020_HCM_2,,0.6116578521757595
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.48700030335289357,0.597985817598234
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.611130079913626
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,0.5126559212657442,
RB2022_5_PostStrength,,0.6056312155178
GF2025_P6_Sph,0.4840871771230505,0.6019537871988934
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.49750801154750157,0.5959063306073448
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4977924084647201,0.6399718557889569
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.6090577565427454
KBE2022_Log2_Ex_34_U,0.5121348583419827,0.6233356974940278
WZ2023_Pu_005_10min,0.4930165472637484,0.6389942318243178
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.6093621572555729
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.4923895564236425,0.6380004928173157
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.4758184188210443,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5041473075072999,0.6070254244602973
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.611187702678951
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.61108507019742
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,0.6154266233632143
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.481899776574118,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5145196556855505,0.624048286106943
HS2024_3_B_N1,0.4860648777557337,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5006212498825103,0.640347341173577
CK2022_11 40-1,,0.6094165542210673
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.49316681933690054,0.5963197113113331
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.4993476856042975,0.6416038998092376
NJH2024_Sub10_MICT_Post,0.4708114315209071,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4900556093999377,0.6038343048263297
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.49129710872594373,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.6223702890463143
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.4768248817480964,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.49649529345944077,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.6058096288831005
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.49411990711595566,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.4572170683559494,0.6049622656351817
CK2022_1 200-1,0.4811023705599286,0.5992584973452357
PG2020_Intensity Mock_10h_D,,0.6003540122402076
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.49066086866702885,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5001914990249359,0.6008893094113286
RCJD2014_5min_1,,0.6114944260853952
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,0.5136797016798605,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.612943581259897
PG2020_Intensity 2h_C,0.4942229752652403,0.6071586411278675
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.49707944427518413,0.5946747906320697
KBE2022_Log2_Ex_8_T,,0.6256251765901589
NJH2025_Sub10_MICT_Post,0.4708114315209071,
HS2024_6_I_T3,0.4880352434950012,
RN2012_L11,,0.5907613198874938
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.503868453319275,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,0.6085280317261598
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5103390678900652,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,0.4686489442336775,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4816238062002926,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,0.4749458760911629,
HS2024_3_B_T1,0.4820446149231908,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.6059301824430542
RB2022_1_PostEndurance,,0.6112313524132038
CR2017_Ratio Replicate 3,0.4863357727670754,0.5811438933240789
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.6106183997382851
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.49739568144318985,0.6003039354478494
HS2024_8_I_T3,0.4937535178822946,
CF2017_EOC 3,,0.6179907743551992
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.4900792423434508,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.49666595237264444,0.6407574658598
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.6085319257541764
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.493098763213441,0.6120241952666474
KS2014_Intensity N3,0.5261857839488642,0.628022571064262
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,0.6098216089628895
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,0.47452486466398375,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.6118993040906617
HS2024_8_PD_T1,0.506795568757515,
JJ2018_Ratio H/L normalized pP2,,0.6065995063771626
CF2017_OSE 27,,0.6073274365846195
KS2014_Intensity E15_2,0.4881580530452978,0.5969684729808911
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.6027378414049533
HS2024_7_I_T1,0.4989722577053351,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.49697076236842724,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.48580975424008277,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.506873449276463,0.6250506140649809
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.6044717180860493
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.610034228182515
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5193237292049044,0.5983497257783301
HS2024_6_B_N1,0.49495337799909506,
KBE2022_Log2_Ex_27_T,0.4921802898355595,0.6231906819282914
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.6138930070457537
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.611158987133772
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.598102343532893
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.6059950027084436
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,0.4791966809425758,
PG2020_Intensity 4h_D,0.4849722957094653,0.5884924163635301
NJH2025_Sub2_MICT_Post,0.4798890311394577,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.48292831710299333,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.6158087825406029
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.4880569185913544,0.6112096069577041
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.6048875280239001
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.4894475482288856,0.6113580802290567
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5015634652581109,0.6052820923019853
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,0.6038218182738108
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.48097588723841683,0.6116009533363757
CK2022_12 200-1,0.4753029737497004,0.6127486570627889
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5009632323987379,0.6431197647007354
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5197010394460767,0.6259727479561238
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.6143154214398004
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.5368804810713865,0.6301836787706083
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.5970286567395631
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.48993000666079733,0.6090668434191343
CK2022_14 200-1,0.4784029547530482,0.609834735113137
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5958422875349009
TM2022_mock.4h.A,0.5131411981430893,
NJH2025_Sub12_HIIT_Pre,0.4795349150000665,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,0.609708249326347
PG2020_Intensity Mock_10h_A,0.48592569561427174,0.6032276238953249
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,0.4798890311394577,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.45673857664440076,0.6061896564410588
GF2025_P1_Adh,0.4824479989966384,0.6096929448898396
GF2025_P1_Sph,0.4726363263170448,0.6031385167736062
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.49359885216607674,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4950910794345744,0.6354805109696335
CF2017_EOC 1,0.4816262657824761,0.6168754052205069
CK2022_3 200-1,0.48174345943301405,0.6011152086510163
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,0.4816176755181211,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,0.4763049493420435,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.6001434869808511
RB2022_3_RecoverySprint,,0.5928547631973343
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.5991269652928152
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.49286825868819323,
HS2024_5_B_T1,0.4842734073815566,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5045536266731434,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.6076165984196905
RB2022_1_PostSprint,,0.6108901577357939
CK2022_4 200-1,0.4818262728227508,0.5999998046087215
JW2021_Before_2,,
TM2022_S2.12h.A,0.5132886913535823,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.4905833634753341,0.6118900549281932
AR2021_ALG 1 μM,0.494458975157047,
HS2024_4_B_T1,0.48730178911285493,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,0.477794609205594,
RCJD2014_5min_3,,0.6116133134030608
CR2017_Ratio Replicate 3.2,,0.6093422181977683
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.48895245436147206,0.5983837387245161
CK2022_9 16-1,0.46329236449130023,0.6113036971174794
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.47807564039629485,0.6095077472626417
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4749028889507332,0.5997833113043003
CK2022_16 16-1,0.45183575196179976,0.6075833275590141
FS2019_db/db3,,
CK2022_15 40-1,,0.6061972581828015
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.4987878174318205,0.6401096811073184
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5101438072622965,0.6244670684441983
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.4973281397207219,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.6258831399701468
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.4875239963747954,0.6219746766181689
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5082228099531557,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.6085542198342601
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.6106536395851845
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5023921425091589,0.609128993288708
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.4624398622927305,0.6129617014631528
RN2012_L13,,0.6121075334449873
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.621890969608849
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.49672597056690493,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4729019839297789,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.6097163721398815
NJH2024_Sub12_HIIT_Pre,0.4795349150000665,
NJH2024_Sub8_MICT_Pre,0.4770254709425718,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.49354569435884266,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4861986988307634,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,0.4829541686638763,0.603260736329734
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.4784042036744058,
KBE2022_Log2_Ex_19_U,,0.6261394270658649
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,0.6256504497710953
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.4818013664751129,
AST2020_Control,,0.6082121942948499
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.6044977304360655
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,0.5136420803896571,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.6204042139274342
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,0.47597857319849624,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.6120680184314068
RB2022_7_RecoverySprint,,0.6036109766815374
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.49641224349802443,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.6273467332747377
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5027360758245573,0.6282095064341183
HH2022_Reporter intensity 1,0.49021472800062127,0.6112505724327074
HH2022_Reporter intensity 2,0.48959091238623886,0.6109785271862286
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5004798347155813,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.4315378286298791,0.607797832338484
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4832464247573841,0.5970317349740619
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.49820136082331623,0.615940275393718
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.482929838129487,0.6229834179454626
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,0.477794609205594,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.5047268894219082,0.6287592776902363
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,0.6265703800319316
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5989753799382437
CF2017_OSE 29,,0.6100269312721082
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.4841894810658279,
PG2020_Intensity 10h_A,,0.6010299144691411
RN2012_L12,,0.602436117416319
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,0.47569357087396896,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.598394467855221
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.6120392330777056
RB2022_7_RecoveryEndurance,,0.6163197459524365
NJH2025_Sub12_HIIT_Post,0.4816176755181211,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,0.5132886913535823,
RN2012_L15,,0.6038049142218188
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,0.5128403569144192,
PG2020_Intensity 4h_A,0.4915972090918913,0.6017031785342857
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,0.5129335126456226,
KBE2022_Log2_Ex_24_U,0.510937614908957,0.6240386401991972
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4854179030595179,0.6108258593332773
RB2022_1_PreSprint,,0.6114710702255512
HS2024_4_I_N1,0.4647855506512957,
CK2022_7 200-1,0.5027214022502359,0.6133539664978125
CK2022_5 200-1,0.4987272473059657,0.6139483525572831
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.6204777848575449
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,0.4732456897324719,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5226390662450722,0.6300200099271567
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.46224481245491333,0.6041116560248562
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.48197896846538424,
JJ2018_Ratio M/L normalized pP2,,0.603808450462252
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.48600982310429985,0.6020080157733612
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.4898635457129682,
JJ2018_Ratio M/L normalized,,0.6078258517387144
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,0.47956257945567515,
HS2024_6_B_N2,0.4918164615564714,
KBE2022_Log2_Ex_9_T,0.5059763924237214,0.6276922023687772
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.4759096609078176,
UK2020_UA_2,,0.6107606164280812
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4872045041852521,0.5934948321378604
WZ2023_Pe_025_20min,0.4980049964764432,0.6393267736390336
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.49056077156573524,
AH2018_TMTMS2_3_N,,
RN2012_H06,,0.6002579633683054
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.48092060652350216,
WZ2023_Su_005_30min,0.4977175840699259,0.6374443481916666
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.6116392488578685
NJH2024_Sub10_HIIT_Post,0.47443914117706354,
CR2017_Ratio Replicate 3.1,0.4881563058328161,0.587580009246059
WZ2023_Su_025_10min,0.49712399925830686,0.6398879502773502
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.4994438175278298,0.641630261583001
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.49199496016055577,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,0.6087158737089406
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5027189393962405,0.5983447243014909
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5095905449473761,0.6257674647662965
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.589931409987736
LY2019_P7+,0.4696375233448163,
EP2017_Untreated R#1 normalized log2 ratio,0.4683843803095652,0.5851906833292907
RN2012_L10,,0.6017650068382296
PG2020_Intensity 4h_C,0.4847699904324549,0.6017952276529239
EP2017_Mitotic R#3 normalized log2 ratio,0.4969159445506267,0.6027518145727727
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.511502736096623,0.6239677388857781
RB2022_8_PostStrength,,0.6117270239224699
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.4973907462574924,
NJH2024_Sub2_HIIT_Post,0.4686489442336775,
HS2024_8_B_N2,0.48199987467202415,
NJH2025_Sub8_HIIT_Pre,0.47597857319849624,
JJ2018_Ratio H/L normalized pP2___1,,0.6066059038658963
HS2024_8_I_T2,0.4848404359551428,
KBE2022_Log2_Ex_6_U,0.5029512483134085,0.6239391812173917
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.46136291678977814,0.6035343553057838
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.6222273835086783
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.47726855718042155,0.6094046425818049
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5038945288342553,0.6045238596323335
GF2025_P9_Sph,0.4990345199007563,0.6020357386443015
CK2022_6 200-1,0.5047247695849206,0.6135527177485846
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,0.4755858078926215,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.4818516188015796,
NJH2024_Sub2_MICT_Mid,0.47956257945567515,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.4788813763500378,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.4985141968827388,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.5956771460470394
PG2020_Intensity 2h_D,0.4706597420912143,0.6021983889759867
EP2017_Untreated R#3 normalized log2 ratio,0.5219181817436285,0.5941799119860891
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5021444348518004,0.6134230621307185
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5039860401576286,0.6134261201209682
RB2022_7_PostEndurance,,0.6056225701890211
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.6200780068383857
TM2022_mock.12h.A,0.514905229095631,
JJ2018_Ratio H/L normalized pP1,,0.6140252080245838
EP2017_Pervanadate R#2 normalized log2 ratio,0.4749631257376446,0.6080142936520462
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.6198808744674189
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.4874560511934127,
KBE2022_Log2_Ex_29_T,0.49270906513789275,0.6285848344222741
HS2024_7_I_T2,0.48368542066740755,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.49731331848027305,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.49495901201671594,0.6144145551391544
PG2020_Intensity CT_C,0.49290047133234405,0.6054899272617662
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5075827435632635,0.6252799074051708
EP2017_Untreated R#3 log2 ratio,0.5234810360509169,0.5957980080020066
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.49757309479264017,0.6074178814041336
HS2024_8_PD_T2,0.4983663520342947,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,0.6270573302266523
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.48957888104378794,
NJH2025_Sub10_MICT_Mid,0.4763049493420435,
KBE2022_Log2_Ex_15_U,0.5059222262900963,0.6200840898396478
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5022014927608511,
RB2022_3_PreSprint,,0.6126185359939889
CR2017_Ratio Replicate 2.3,0.4919154575391618,0.5882057952892625
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4877361789693896,0.6055356105553844
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4829556280614848,
HS2024_3_PD_T3,0.4850994143374395,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,0.4708691089365236,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.6117545714947027
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.6262636871578499
CK2022_2 16-1,0.4593245795630042,0.6057481288569504
RAM2015_Log2 B,,0.6175143201598617
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,0.4770254709425718,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,0.6012907698379915
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.49382990582944347,
UK2020_HCM_5,,0.6111342581784691
NJH2025_Sub10_HIIT_Post,0.47443914117706354,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.4782611793160376,
PG2020_Intensity Mock_10h_B,0.4724466622013741,0.6064209780227257
WZ2023_Su_025_30min,0.4977838055876883,0.6431643598954274
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,0.6123118624305717
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.47104231528821183,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,0.6205982145269374
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.4957589021288943,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.49321650954051355,0.6095465228517478
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5045253830111315,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.6032904917255617
KS2014_Intensity C5,0.4450746215021719,0.6073874642262607
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,0.4802832475149713,
RB2022_3_RecoveryEndurance,,0.6056929184536298
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5129648320558214,0.6122411994587156
RB2022_3_PostStrength,,0.6111913516291494
TM2022_S2.8h.A,0.512712010367277,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,0.4806271055283014,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.49225077895731184,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,0.4769792771556435,
PG2020_Intensity 8h_B,,0.5938940529120341
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.4837170720383831,0.6069464691522087
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.48737203587902284,0.5959452292229479
GF2025_P3_Sph,0.477561887134586,0.6083775408187295
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.611909168355393
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,0.6107723888463197
CR2017_Ratio Replicate 2.4,0.48140745615389696,0.5918521232961961
ZQ2022_N1,,
LY2019_P6-,0.48878925651483135,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.6105421434263725
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,0.4805544163916915,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.6014535297034677
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,0.5139754800607254,
SFR2015_HL_log2_ratio_std_b,0.49073781692220536,
UK2020_UA_1,,0.6103821108513041
KBE2022_Log2_Ex_13_U,,0.6226918389827297
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.6066728286305685
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.6227160296451069
JJ2018_Ratio H/L normalized pP3,,0.606232453006992
CK2022_7 40-1,,0.611297677149508
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,0.4732456897324719,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.4898364477267767,0.6006253010781916
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,0.6094235422316514
RB2022_5_PostEndurance,,0.6068933155861657
HS2024_5_PD_T2,0.47092816705785345,
WZ2023_Su_025_20min,0.49859614245889855,0.6392664426099414
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.4907382705510571,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.6215432349035732
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,0.4802832475149713,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.6213147390084791
CK2022_13 40-1,,0.605792979360332
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.5902082154251972
PG2020_Intensity 10h_D,0.48356809949420576,0.596641559009561
RB2022_8_PreEndurance,,0.6106959078072506
HS2024_3_B_N2,0.4936427416512754,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.487700598387318,0.5988721465288257
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.5711340898178191
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.6194608165516715
RN2012_H04,,0.6032172126772517
CK2022_6 40-1,,0.6121351518975502
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5239861440978536,0.6263713025939639
LY2019_P3-,0.47751998931726913,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.49644781390853715,0.6379639261762442
HS2024_8_PD_T3,0.508853418934062,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,0.6092441138597289
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.6021382990090571
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.49699556457339333,0.6405801613953894
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.49364787650695846,0.5999386608173015
RB2022_1_RecoveryStrength,,0.604950367153567
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.4819303773831056,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.49020737206142384,
RB2022_3_RecoveryStrength,,0.6109773113675224
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,0.49872602804193916,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,0.6098694874041848
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.6151691309863109
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.6101399010641387
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5150270561165162,0.6239549859031054
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.4855379896068834,0.6136437622447702
LY2019_P2-,0.4873181147891361,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,0.6062809628189191
RB2022_8_RecoveryStrength,,0.6065245328867659
WZ2023_Pe_005_20min,0.4989393424583395,0.638683207243057
AST2020_Control.2,,0.6082203906794833
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.5888477350094709
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.4890304254847404,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.608556349517862
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.4824069219622614,
HS2024_6_I_T1,0.48795899934703335,
HS2024_5_B_T3,0.49375218362381723,
JJ2018_Ratio H/M normalized pP1___1,,0.6042050071946139
KBE2022_Log2_Ex_36_U,,0.621410108420384
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,0.4769792771556435,
EP2017_Mitotic R#3 log2 ratio,0.49695633426326014,0.6029142425038275
KBE2022_Log2_Ex_36_T,0.472628335516297,0.6231608182984529
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4965509351706373,0.6395560074185274
KS2014_Intensity C2,0.4850730858394537,0.6170798883841299
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5203785219917737,0.627598282047132
CK2022_9 200-1,0.4847430759295124,0.6114412799362661
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.489459054785294,0.6116620650312032
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.4769192331575771,
RBK2021_1332T Late,,
LY2019_P1-,0.500832130466513,
RKK2015_TNF-α/basal.1,0.4959704871760914,
RKK2015_TNF-α/TNF-α+SC-514,0.4876663113822117,
CR2017_Ratio Replicate 2.5,0.4785402256037796,0.5975947970844808
HS2024_3_I_T3,0.5049673975547324,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.6213790528985044
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.4727698073200016,0.6024726276660372
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5073520761819587,0.6252585794482094
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.46924942206981385,0.5866119251950164
RKK2015_SC-514/basal,0.4925157163856396,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5018836852341765,0.6418592665944991
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.4927580992957712,
KS2014_Intensity N1,0.499303768043344,0.6295515641535149
NJH2024_Sub12_MICT_Post,0.4805544163916915,
TM2022_S2.8h.C,0.5137162934238607,
CR2017_Ratio Replicate 1,0.5068973434639759,0.6041625652427478
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,0.6226343525942006
JJ2018_Ratio H/M normalized pP3,,0.6013860434245518
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.47854033194212614,0.6034135609210186
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,0.6061039335607048
RCJD2014_15min_2,,0.5970875949592325
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5898290081803712
HS2024_5_B_N2,0.4986244268280995,
HS2024_5_I_N1,0.5004468371309945,
HS2024_6_I_N1,0.5053634851069188,
AR2021_KD 48h,0.4832240996259921,0.6053612266678533
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.6065912706620626
HS2024_5_I_T1,0.493328981039831,
NJH2024_Sub10_MICT_Pre,0.4773957309557579,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.6085099404234028
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4991617875691097,0.6410672457294141
KBE2022_Log2_Ex_29_U,0.490327270481124,0.6282814667036641
HS2024_7_B_T1,0.4968640378848709,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.47756113017085344,0.6092202213151248
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,0.6062106185247351
JJ2018_Ratio M/L normalized pP3___1,,0.615122824801028
KBE2022_Log2_Ex_34_T,0.5113713449815841,0.6244438377296471
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.6232614408267354
LY2019_P2+,0.4777553624347312,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.47941883412892927,0.5992207229813792
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4985421775847235,0.6409523561775605
RN2012_H01,,0.6070548916275558
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.6017416337027582
EP2017_Pervanadate R#1 normalized log2 ratio,0.5021551006567396,0.5975573698453495
HS2024_8_B_T3,0.5020879368020971,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5005600601290151,0.6232371718891759
WZ2023_Pe_010_20min,0.4956249662051499,0.6380504976166205
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.6157035498741628
RB2022_3_PreStrength,,0.611199763684889
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.602895581864707
KS2014_Intensity C1,0.4700738728818807,0.6115831114883897
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,0.47575673900982446,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5082191231239226,0.6215590485158754
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5003940809006902,0.6414170430563563
PG2020_Intensity 6h_C,0.4881181496082204,0.5990646812274335
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,0.6105670024114358
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,0.45870876362031276,0.6067175621652451
CK2022_3 16-1,0.4624669094275285,0.6046431025156584
LY2019_P4-,0.48492643002893715,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.49453261395660464,
GF2025_P8_Adh,0.5095970701423994,0.6099767077927669
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.4857671007777127,0.6017719582500026
CK2022_10 16-1,0.47421539365944904,0.6116013186755829
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.605460367510972
NJH2024_Sub2_HIIT_Mid,0.4734505842698167,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,0.4791966809425758,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.6113938701299183
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5027866117665243,0.6034462799073157
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.6250650936603066
CF2017_FTE 16,,0.6157003887938786
AR2021_L41 10 μM,0.49603834266668084,
CF2017_EOC 2,,0.6197901095621491
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,0.4708691089365236,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.6114324777093808
RB2022_7_PreSprint,,0.5974309700109999
NJH2024_Sub2_MICT_Pre,0.4806271055283014,
HS2024_3_PD_T2,0.5013593216405238,
CK2022_6 16-1,0.4976764218205706,0.6126758639059717
ZX2022_CB treated Replicate 1,0.49726761395779173,0.5930935684314883
BS2014_Log2(Ratio H/L normalized Rep_3),,0.5990438218772971
TM2022_mock.12h.C,0.5145511320922778,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4899436963320233,0.6109871124848535
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.6116293795719451
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,0.4944971093149481,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,0.4773957309557579,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.49489811641425696,0.5914630490654257
KS2014_Intensity C4,0.47452403797513765,0.608130051250211
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.48984736621409786,0.626348708055415
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.5940607445579523
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.4943384266696793,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,0.4734505842698167,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,0.6246324052330869
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.6097371057404783
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.4935881731063739,0.6419787876550721
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.6025072910706504
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.6199714055888745
JJ2018_Ratio H/L normalized pP1___1,,0.61154905136562
WZ2023_Pe_010_30min,0.4975332364719062,0.638949757677778
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.4706614278792215,0.604255974474796
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.6087053163098871
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4963248175177476,0.5931333932465013
JJ2018_Ratio H/M normalized pP1,,0.6041806159332028
CK2022_16 40-1,,0.6053381991347689
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,0.6129384955105238
AH2018_LFQ_3_X,,
UK2020_UA_3,,0.6113495799917498
LY2019_P7-,0.47601498335614384,
GF2025_P5_Adh,0.49813905097682665,0.6060846485696022
RB2022_1_PostStrength,,0.6143215273150724
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4818741172481326,0.587493811748064
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.46559941095236707,0.6097452339448534
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.47712500075942715,0.5709612093486791
PG2020_Intensity CT_B,0.4792585724211251,0.606114407138943
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.6114459484080689
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,0.4755858078926215,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.47724600803672657,0.6057831570981175
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5282027453301097,0.6298103586500061
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,0.6079600823657937
FR2021_Intensity.H,,
CK2022_14 16-1,0.45586756368850134,0.6068397358921792
AST2020_anti-CD3+PDL2,,0.6087187568234532
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.6206408082084153
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,0.604536924808954
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.4997705226797708,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.499234741839445,0.5997245308660064
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,0.47569357087396896,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.486731497593463,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,0.5143714553364385,
NJH2024_Sub12_MICT_Pre,0.4811115850034188,
RCJD2014_15min_3,,0.6147668185972269
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.6148513016661837
HS2024_4_I_T3,0.47747347974813187,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,0.4826874205694835,0.5945941615867297
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,0.4821485992800774,0.616792282927213
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5036495277653702,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.48927673212257283,0.5977408454914548
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.6267115742476
EP2017_Untreated R#2 normalized log2 ratio,0.43106914561978843,0.6061781991881339
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.48916806345461966,
HS2024_5_I_N2,0.49022449284397485,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.47574525066047385,0.6089788086003682
AS2011_Ratio H/L Normalized RNAi_2_1,,
